001     293613
005     20241204134931.0
024 7 _ |a 10.1158/1078-0432.CCR-24-2100
|2 doi
024 7 _ |a pmid:39320341
|2 pmid
024 7 _ |a 1078-0432
|2 ISSN
024 7 _ |a 1557-3265
|2 ISSN
024 7 _ |a altmetric:168551223
|2 altmetric
037 _ _ |a DKFZ-2024-01929
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Kalish, Jennifer M
|0 0000-0003-1500-9713
|b 0
245 _ _ |a Update on surveillance for Wilms tumor and hepatoblastoma in Beckwith-Wiedemann Syndrome and other predisposition syndromes.
260 _ _ |a Philadelphia, Pa. [u.a.]
|c 2024
|b AACR
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1733316549_12765
|2 PUB:(DE-HGF)
|x Review Article
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a 2024 Dec 2;30(23):5260-5269
520 _ _ |a Wilms tumors are commonly associated with predisposition syndromes many, but not all, of which include overgrowth. Several of these syndromes also include a risk of other embryonal malignancies - particularly hepatoblastoma. Guidelines for surveillance in this population were published in 2017 and recently members of the AACR Pediatric Cancer Working Group met to update those guidelines with a review of more recently published evidence and risk estimates. This perspective serves to update pediatric oncologists, geneticists, radiologists, counselors and other healthcare professionals on revised diagnostic criteria, review previously published surveillance guidelines and harmonize updated surveillance recommendations in the North American and Australian context for patients with overgrowth syndromes and other syndromes associated with Wilms tumor predisposition.
536 _ _ |a 312 - Funktionelle und strukturelle Genomforschung (POF4-312)
|0 G:(DE-HGF)POF4-312
|c POF4-312
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
700 1 _ |a Becktell, Kerri D
|0 0000-0002-1935-5157
|b 1
700 1 _ |a Bougeard, Gaëlle
|0 0000-0002-1475-0254
|b 2
700 1 _ |a Brodeur, Garrett M
|0 0000-0002-6721-122X
|b 3
700 1 _ |a Diller, Lisa R
|0 0000-0002-4073-5509
|b 4
700 1 _ |a Doria, Andrea S
|0 0000-0003-3202-0447
|b 5
700 1 _ |a Hansford, Jordan R
|0 0000-0001-7733-383X
|b 6
700 1 _ |a Klein, Steven D
|0 0000-0001-8634-0388
|b 7
700 1 _ |a Kohlmann, Wendy K
|0 0000-0002-9134-9640
|b 8
700 1 _ |a Kratz, Christian P
|0 0000-0003-4120-5873
|b 9
700 1 _ |a MacFarland, Suzanne P
|0 0000-0001-5894-6403
|b 10
700 1 _ |a Pajtler, Kristian
|0 P:(DE-He78)a7c1bbac024fa232d9c6b78443328d9d
|b 11
|u dkfz
700 1 _ |a Rednam, Surya P
|0 0000-0001-8333-0758
|b 12
700 1 _ |a Schienda, Jaclyn
|0 0000-0003-2543-8378
|b 13
700 1 _ |a States, Lisa J
|0 0000-0003-0260-3975
|b 14
700 1 _ |a Villani, Anita
|0 0000-0003-3283-2197
|b 15
700 1 _ |a Weksberg, Rosanna
|0 0000-0002-6501-4150
|b 16
700 1 _ |a Zelley, Kristin
|0 0000-0003-0970-1850
|b 17
700 1 _ |a Tomlinson, Gail E
|0 0000-0003-2579-1833
|b 18
700 1 _ |a Brzezinski, Jack J
|0 0000-0002-9475-0077
|b 19
773 _ _ |a 10.1158/1078-0432.CCR-24-2100
|0 PERI:(DE-600)2036787-9
|n 23
|p 5260-5269
|t Clinical cancer research
|v 30
|y 2024
|x 1078-0432
909 C O |p VDB
|o oai:inrepo02.dkfz.de:293613
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 11
|6 P:(DE-He78)a7c1bbac024fa232d9c6b78443328d9d
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-312
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Funktionelle und strukturelle Genomforschung
|x 0
914 1 _ |y 2024
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-08-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-08-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2023-08-25
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2023-08-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-08-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2023-08-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2023-08-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2023-08-25
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b CLIN CANCER RES : 2022
|d 2023-08-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-08-25
915 _ _ |a IF >= 10
|0 StatID:(DE-HGF)9910
|2 StatID
|b CLIN CANCER RES : 2022
|d 2023-08-25
920 1 _ |0 I:(DE-He78)B062-20160331
|k B062
|l B062 Pädiatrische Neuroonkologie
|x 0
920 1 _ |0 I:(DE-He78)HD01-20160331
|k HD01
|l DKTK HD zentral
|x 1
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)B062-20160331
980 _ _ |a I:(DE-He78)HD01-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21